Prevention of Perinatal Group B Streptococcal Disease --- Revised Guidelines from CDC, 2010
CE Original Date: 11/19/2010
CE Renewal Date:
CE Expiration Date: 04/20/2013
Goal
This report provides updated recommendations for the prevention of early-onset group B streptococcal (GBS) disease. Upon completion of this educational activity, the reader should be able to
Objectives
Describe recommended GBS screening practices for pregnant women;
Describe which women should receive intrapartum antibiotic GBS prophylaxis;
Describe recommended laboratory practices for processing specimens collected for GBS testing in pregnant women; and
Describe the recommended management of newborns in order to rapidly detect and treat cases of early-onset GBS disease
Intended Audience
All
Presenters/Content Experts
Leslie M. McGee, PhD, Microbiologist, Division of Bacterial Diseases, NCIRD/CDC
Stephanie Schrag, DPhil, Epidemiologist, Division of Bacterial Diseases, NCIRD/CDC
Jennifer R. Verani, MD, Medical Officer, Division of Bacterial Diseases, NCIRD/CDC
Accreditation
Continuing Nursing Education (CNE) Credit
The CDC is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 2.7 contact hours.
Continuing Medical Education (CME) credit
The CDC is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The CDC designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
IACET Continuing Education Unit (CEU) Credit
The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA. The CDC is authorized by IACET to offer 0.3 ANSI/IACET CEU's for this program.
